The HABRI Foundation is calling for research proposals to investigate the health outcomes of pet ownership and/or animal-assisted activity or therapy, both for the people and the animals involved. To learn more, visit https://habri.org/grants/funding-opportunities/ close

 
You are here: Home / Journal Articles / An evaluation of dirlotapide to reduce body weight of client-owned dogs in two placebo-controlled clinical studies in Europe / About

An evaluation of dirlotapide to reduce body weight of client-owned dogs in two placebo-controlled clinical studies in Europe

By J. Gossellin, J. McKelvie, J. Sherington, J. A. Wren, J. S. Eagleson, T. G. Rowan, S. J. Sunderland

View Resource (HTM)

Licensed under

Category Journal Articles
Date 2007
Publication Title Journal of veterinary pharmacology and therapeutics
Volume 30
Pages 73-80
ISBN/ISSN 0140-7783 (Print) 0140-7783 (Linking)
DOI 10.1111/j.1365-2885.2007.00866.x
Language eng
Author Address Pfizer Ltd, Veterinary Medicine Research and Development, Sandwich, Kent, UK. jacques.gossellin@pfizer.com
Cite this work

Researchers should cite this work as follows:
Tags
  1. Administration
  2. Body weight
  3. Breeding
  4. Dog diseases
  5. Dogs
  6. Europe
  7. Females
  8. Males
  9. Ownership
  10. peer-reviewed
  11. Treatment outcomes
  12. Weight
Badges
  1. peer-reviewed